CN104137965A - 雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥 - Google Patents
雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥 Download PDFInfo
- Publication number
- CN104137965A CN104137965A CN201310341019.8A CN201310341019A CN104137965A CN 104137965 A CN104137965 A CN 104137965A CN 201310341019 A CN201310341019 A CN 201310341019A CN 104137965 A CN104137965 A CN 104137965A
- Authority
- CN
- China
- Prior art keywords
- highland barley
- pilose antler
- deep
- add
- compound health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003056 antler Anatomy 0.000 title claims abstract description 49
- 235000007340 Hordeum vulgare Nutrition 0.000 title claims abstract description 43
- 102000008186 Collagen Human genes 0.000 title claims abstract description 33
- 108010035532 Collagen Proteins 0.000 title claims abstract description 33
- 229920001436 collagen Polymers 0.000 title claims abstract description 33
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 230000036541 health Effects 0.000 title abstract description 22
- 235000021395 porridge Nutrition 0.000 title abstract 2
- 240000005979 Hordeum vulgare Species 0.000 title 1
- 241000209219 Hordeum Species 0.000 claims abstract description 43
- 241000209140 Triticum Species 0.000 claims abstract description 14
- 235000021307 Triticum Nutrition 0.000 claims abstract description 14
- 210000000988 bone and bone Anatomy 0.000 claims description 29
- 241000251468 Actinopterygii Species 0.000 claims description 20
- 235000011194 food seasoning agent Nutrition 0.000 claims description 8
- 238000011109 contamination Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000015203 fruit juice Nutrition 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 230000003143 atherosclerotic effect Effects 0.000 claims description 3
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 2
- 241000220225 Malus Species 0.000 claims description 2
- 235000011430 Malus pumila Nutrition 0.000 claims description 2
- 235000015103 Malus silvestris Nutrition 0.000 claims description 2
- 235000019219 chocolate Nutrition 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 15
- 230000035764 nutrition Effects 0.000 abstract description 11
- 239000000047 product Substances 0.000 abstract description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 10
- 239000013589 supplement Substances 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 229920000945 Amylopectin Polymers 0.000 abstract description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 4
- 230000001093 anti-cancer Effects 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 4
- 239000000835 fiber Substances 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 239000011669 selenium Substances 0.000 abstract description 4
- 229910052711 selenium Inorganic materials 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 230000037213 diet Effects 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 231100000614 poison Toxicity 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 2
- 229920002472 Starch Polymers 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 230000008030 elimination Effects 0.000 abstract description 2
- 238000003379 elimination reaction Methods 0.000 abstract description 2
- 210000004347 intestinal mucosa Anatomy 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 235000019698 starch Nutrition 0.000 abstract description 2
- 239000008107 starch Substances 0.000 abstract description 2
- 210000002435 tendon Anatomy 0.000 abstract description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 2
- 229920002498 Beta-glucan Polymers 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 101710172711 Structural protein Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000002398 materia medica Substances 0.000 abstract 1
- 239000002574 poison Substances 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- 102000039446 nucleic acids Human genes 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 13
- 150000007523 nucleic acids Chemical class 0.000 description 13
- 235000012054 meals Nutrition 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 235000001465 calcium Nutrition 0.000 description 9
- 235000015961 tonic Nutrition 0.000 description 9
- 230000001256 tonic effect Effects 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000000845 cartilage Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 208000001132 Osteoporosis Diseases 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000003170 nutritional factors Nutrition 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000005772 leucine Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 108010048734 sclerotin Proteins 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010057178 Osteoarthropathies Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010036941 Prostatic atrophy Diseases 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 201000006488 atrophy of prostate Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004692 intercellular junction Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
人类健康长寿追求营养全价，当今更要注重清除环境和食品污染造成的自身体内污染，其最佳举措是膳补食疗多功能青稞复方保健粥。青稞是产于世界屋脊的独特物种，富含五大营养要素和抗癌元素“硒”。可溶性和不可溶性疗效纤维16％，能排除毒物毒素。淀粉特殊74-78％是支链淀粉，特别是β-葡聚糖高达6.75％是小麦的50倍，可减少肠道粘膜与有害物质接触，能抑制合成血脂、血糖、胆固醇防控“三高”。古籍《晶珠本草》记载青稞是重要药物。本品配伍深海鱼骨胶原补充人体支架、肌腱、皮肤、头发所需的结构蛋白质。并加入微量鹿茸增强生理功能。本品纯天然、药食同源，食补五大营养要素，膳疗体内污染，健体抗衰，是多功能新一代保健品。
Description
关键词：
雪域青稞麦
深海鱼骨胶原蛋白
鹿茸(或鹿茸腊片细胞)、活性核酸
古今中外人类社会所追求的最大目的是幸福健康与长寿，我们的祖先在战天斗地的过程中共识一条哲理：“民以食为天”，不仅要吃得饱、吃得好，还应吃出健康来。当代人孜孜追求健康与长寿，认识到科学膳食的重要性。近代营养科学强调膳食五大营养要素，追求全价，保证人体营养所需，随之各类补品应时而生，琳琅满目，功效各一，价格不菲，从营养科学而论确属一大进步。
由于人类活动所产生的空气、水、土壤环境严重污染，导致食物污染，今日各种食物和补品已非往昔天然和纯净，可能是毒物、毒素病原的携带者，“病从口入”因此造成的危害入侵体内，由环境污染转为机体内部污染，日积月累有增无减触目惊心。此类发生在各国的事件屡有媒体报道，谈害色变。各种污染时时入侵人体，防不胜防，人们已难以回 避各种污染所带来的对身体损害。人类健康长寿面临非常严峻的挑战，仅靠医药难以救治这一社会性问题。另外，以往生产的膳食补品的主流是补充钙、维生素、蛋白质、氨基酸、鹿茸等作用单一的保健品，不能满足人体健康的时代需求。人类健康长寿迫切要求科学膳食保健必须向深层次营养发展，保健食品标准必须是“天然”“纯净”“多功能”，达到即能补充营养物质满足身体热量，又能抑制进入体内的毒物毒素，治理体内污染增进健康，具有双向功效。
近年，生命科学发现核酸是生命之源，并且找到一些影响生命发挥作用的活性因子。由于核酸能够自我复制，并能依其编码复制合成蛋白质，因此，现时食补食疗新理念是在摄食五大营养要素的同时，还应膳补必需的核酸及重要的生命因子，从生命的源头确保机体健康生长发育、遗传繁殖、新陈代谢，提高免疫力，修复组织器官，防病抗衰，使生命进程正常进行并能够得以延长。
我们遵照这一科学理念研制了新一代膳食保健品“雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥”。其配方组份为：
(1)雪域青稞麦。青稞是禾谷作物，青稞的种子与壳完全分离故名为青稞。选自生长在世界屋脊海拔3000米以上雪域高原无污染的青稞为产品主要原料。高寒缺氧、空气稀薄、阳光充沛独特的自然条件造就了青稞的特殊品质。
(2)深海鱼骨胶原蛋白。其来自远洋深海，以深海鱼骨制成，产于北美。深海鱼骨胶原蛋白是目前世界上最好的骨胶原蛋白之一。
(3)鹿茸(或鹿茸腊片细胞)。鹿茸是我国传统名贵补品，近代科学研究证明，鹿茸含有丰富的生命活性物质。鹿茸(或鹿茸腊片细胞)属于药食同源，短期量大多用起医疗作用，少量长期慢用常用则是保健佳品。
本品含有活性核酸，并含有多种特殊的活性物质，从生命源头补充生命物质，故称雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥。
利用生产线制作青稞粥，添加深海鱼骨胶原、鹿茸(或鹿茸腊片细胞)果汁调味，分装入易拉罐冷藏，每日食补1-2罐。
雪域青稞、深海鱼骨胶原蛋白、鹿茸复方系列保健粥的化学成分及功效：
一、青稞
青稞是禾谷作物，选自西藏海拔3000米以上雪域高原无污染的青稞为产品原料。独特的自然条件造就了青稞的特殊品质，独特的成分如下：
1、青稞B-葡聚糖平均含量为6.57％，高于小麦50倍，。B-葡聚糖能减少肠粘膜与致癌物质接触，预防癌症的发生。并能降低血脂和降低胆固醇的合成，预防心血管病的发生。通过控制血糖，预防糖尿病，具有提高机体防御能力作用。
2、美国学者从青稞麦中发现一种胆固醇抑制因子，其含量每公斤为100-150毫克。
3、青稞淀粉成分独特，其中含有74-78％支链淀粉，加热后呈现弱碱性。支链淀粉含有大量凝胶，可抑制过多的胃酸，保护病灶起到屏障作用。
4、青稞含植物蛋白8-14％，可为素食者及减食红肉提供营养所需。
5、有疗效作用的膳食纤维丰富，占16％。其中不可溶性疗效纤维为9.68％，是小麦的8倍。可溶性疗效纤维为6.37％，是小麦的15倍。膳食纤维是人体清肠通便、排除毒素的清道夫。
6、青稞含有多种有益健康的微量元素，不仅有钙、磷、铁、铜、锌，还有硒。硒是世界卫生组织确定的防癌抗瘤的人体必需微量元素。青稞富含多种维生素营养成分，每100克青稞含量为：硫胺素0.32mg、核黄素0.2mg、尼克酸3.6mg、维生素E0.25mg，这些人体必需的维生素对保持健康促进发育十分重要，应通过膳食不断补充。
7、世界屋脊雪域高原，阳光明媚、空气稀薄、高寒干燥，特殊的地域自然生态环境，造就了青稞麦的特殊品质，是不施农药化肥，环保无污染。藏族同胞自古赖以膳食青稞战胜和适应生存条件生生不息，形成健强体魄，不乏百岁老人。
二、深海鱼骨胶原蛋白
骨胶原又称“构造蛋白质”，占人体蛋白总量的30-40％。组成人体支架，分布于肌肉与骨连接的肌缝、关节与软骨以及它连接的结缔组织，广泛存在于皮肤的真皮层与毛发之中。总的概括起来，人体60兆个细胞连接处都需骨胶原。骨胶原构成人体支架，使人体站立起来，保持人体活力，维持皮肤不生皱纹和保持肌肉弹性。特别是对维持机体正常生理功能、保持生命力，延缓衰老均有重大作用。当年龄增加生理变化，机体中胶原蛋白和水分流失不断减少，这也是生命的老化、退化的开始。此时胶原蛋白纤维开始变为细小，弹力蛋白的弹性降低。有胶原蛋白和弹力蛋白所交互构成的有规则的网目结构会不断崩解，导致皮肤皱纹、肌肉萎缩的生成，以及钙、磷的流失，致使骨质脆弱、疏松等病患的发生。应该注意到，此时补钙已无济于事，因为钙已不能在骨骼中沉着，多吃钙也会流失，只有补充胶原蛋白能够根除问题。
深海鱼骨胶原的作用：
第一：消除骨关节病。最新的骨科学发现：关节疼痛、肿胀、僵硬、无力感、嘎嘎作响、其软骨磨损的根源是骨胶原受到免疫系统的错误攻击，绝非缺钙造成！
因为人体自身对一种名为爱泼斯坦(EpsteinBarr，EB)的病毒有遗传性的先天性过敏，而这种病毒的氨基酸和人体 骨胶原内的氨基酸非常相似，所以当人体免疫系统产生抗体攻击爱泼斯坦病毒时，也错误地把软骨内的骨胶原当成外来异物加以攻击(也称″免疫交叉反应″)，因而使软骨受损，润滑度变差；软骨表面长出骨刺，肿胀，关节间的空隙变小，活动受阻，疼痛不已，如果缺乏治疗，最终将导致骨头破裂。
骨胶原经过胃，被小肠淋巴识别后，使免疫系统产生″耐受″认同作用，直达软骨组织，快速修复软骨，消除关节的疼痛、肿胀、僵硬、无力感、有响声、骨质增生、骨刺、等。这个过程是“口服免疫耐受”(OralTol erization)。补钙无法作到这一点。故补钙不能替代食补骨胶原蛋白，唯有经常食补骨胶原蛋白才能免除骨病，保障健康抗衰防老。
第二：延缓骨质疏松
骨质疏松、腿脚抽筋的主要原因是占骨质总量80％的骨胶原的流失，钙、镁、磷的流失量只占20％，只有补充足够的骨胶原，才能保证骨骼成分的合理比例，延缓骨质疏松。
第三：营养头发指甲
骨胶原是细胞膜的成膜物质，有生物活性，好吸收，故还能营养头发、指甲、皮肤，滋补心脏血管壁、眼球、视网膜斑点。
第四：改善皮肤
有效补充皮肤所流失的胶原蛋白，增加皮肤的弹性，减少皱纹，改善松弛现象，使粗糙的皮肤变得细腻，平滑富有弹性。
自深海鱼类中提炼的100％胶原蛋白，提供皮肤保湿修护，不仅能深度滋润肌肤紧实，有效改善毛孔粗糙、细纹的问题。
膳食深海鱼骨胶原的重要性：
骨胶原是存在于人体和动物体内的胶原蛋白的一种，是人体关节软骨，骺软骨和骨小梁的主要成份，骨骼有机物中有70％～86％是骨胶原。骨胶原也是组成人体肌肉、皮肤的重要成分，对于保持骨骼的韧性、人体运动的协调性及皮肤的弹性有很大帮助。活性骨胶原是由粘多糖和胶原蛋白组成。它是人体必需的一种非常特殊的营养物质，广泛存在于内脏、骨骼、皮肤、肌腱、筋膜、毛发、心血管等各个组织。人类衰老和疾病的发生就是活性骨胶原流失的过程和产生的结果，所以活性骨胶原被喻为“细胞培养液”、“生命的原浆”。活性骨胶原对人体健康重要意义是由粘多糖与体内细胞合成，快速形成蛋白多糖聚合体。由于蛋白多糖聚合体具有负电性，因此它能像磁铁一样吸引、接纳氨基酸、维生素、水分子、矿物质等正电性营养物质，促进人体细胞的增殖、分化和新陈代谢，增强人体组织活性，提高生命质量。
日常饮食中的活性骨胶原营养很难满足人体代谢的需要。正因为大多数人都不同程度的缺乏活性骨胶原的营养，如果长时间得不到补充，将给人体带来各种不良后果和疾病，例如：个子矮小、免疫力低下、骨质疏松、骨关节炎、椎间盘突出、骨质增生、血管硬化、血糖增高、皮肤粗糙老化、便秘、白领人群电脑腕肘病等，甚至引发癌症。
以上所述，补充骨胶原蛋白意义重大，无论对青少年、中壮年、老年各类人群都非常重要。
三、鹿茸(或鹿茸腊片细胞)及活性核酸
鹿茸腊片细胞是所有哺乳动物生长速度最快的细胞，仅约60天左右长成鹿茸。用取自鹿茸生长点的腊片细胞以悬浮培养技术大量生产获得来自天然的鹿茸细胞。
鹿茸及鹿茸腊片细胞的化学成分检测是采白鹿茸角尖部位母细胞，
饮食鹿茸(或鹿茸腊片细胞)的重要营养保健作用：
(一)能增强副交感神经末梢的紧张性，促进恢复神经系统和改善神经、肌肉系统功能，同时对交感神经亦有兴奋作用。
(二)可降低血压。抑制胆固醇的生成，扩张血管，改善血流，纠正心肌代偿不良，促进血管壁再生，抑制血小板凝集，对脑血栓、心肌梗死、高血压和动脉粥样硬化症有较好的营养保健作用。
(三)能增加血浆睾酮浓度，能使促黄体生成素(LH)浓度增加。对青春期的性功能障碍、壮、老年期的前列腺萎缩症、女性更年期障碍有恢复作用。
(四)具有较强的抗疲劳作用，能增强耐寒能力，加速创伤愈合和刺激肾上腺皮质功能。
(五)具有抗生物氧化、消除体内自由基和全面增强免疫。能抑制MAO-B的活性，有抗衰老作用。对于婴儿、迅速成长期的孩子、老年体弱多病、全身感染、外伤手术者、肝功能不全以及白细胞、T细胞、淋巴细胞降低人群等，可以额外补充核酸类物质。世界卫生组织认为，每天补充小于1.5克核酸是合适的。
鹿茸(或鹿茸腊片细胞)主要成分有：
1、鹿茸含有多种活性物质，富有鹿茸核酸。采用鲜鹿茸(鹿茸腊片细胞)完全保留了核酸的活性。
2、多胺：腐胺含量为1955.4nM/g，精脒191.45nM/g，精胺为48nM/g。
3、牛磺酸等抗衰老物质。
4、促生长因子。
5、蛋白质：蛋白质含量为37.67％，含氮量为6.03％。
6、氨基酸和微量元素：鹿茸细胞中含有甘氨酸(glycine)、赖氨酸(lysine)、精氨酸(arginine)、天冬氨酸(asparticacid)、谷氨酸(glutamicacid)、 脯氨酸(proine)、丙氨酸(alanine)、亮氨酸(leucine)等17种以上氨基酸，包括7种人体必需氨基酸和2种人体半必需氨基酸。
实例一：雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥，以青稞为基础原料，辅加深海鱼骨胶原蛋白、鹿茸或鹿茸腊片细胞活性核酸制成复方系列保健粥。含有生命遗传物质核酸以及构成肌体的胶原蛋白、支链淀粉、人体必需的多种维生素、硒等微量元素，以先进工艺制粥状易食保健品。以一罐食补满足五大营养要素及补充人体必需的核酸物质。
实例二：精选雪域高原青稞麦，清洗青稞麦干燥，破碎成三分之一碎粒，称重加矿泉水(PH7.2)侵泡1-2小时，置入锅中，以慢火煨煮至粥状，降温至摄氏20度以下，添加骨胶原蛋白、鹿茸(鹿茸腊片细胞)，分装入易拉罐封口包装。全程无菌操作。入库冷藏保存，保质期三个月。
实例三：选用深海鱼骨胶原蛋白，经国家法定部门检测质量合格，灭菌处理加入降温至20℃以下的青稞粥中，每包装单位含量1500毫克。
实例四：每包装单位含鲜鹿茸750毫克。
实例五：或采用发明专利技术(专利号：200710064481.2)培养鹿茸腊片细胞大规模生产，计数向基质中按每包装单位加入鹿茸腊片细胞250万个。
实例六：向基质中加入经检测无污染的果汁(苹果、草莓、菠萝)调味，或加入咖啡、巧克力调味，以满足不同地区、不同人群口味的需要。
实例七：确保产品纯正，绝不加入其它物质。在全部工艺制造过程中保持营养成分不受破坏，无微生物污染。
实例八：生产线及易拉罐均采用机械化生产设备和先进工艺无菌生产。
雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥罐装净重330-500克，营养成分为：
一、雪域青稞植物蛋白8-14％、B-葡聚糖6.57％、胆固醇抑制因子每公斤青稞约含100-150毫克、膳食总疗效纤维16％。含有抗癌防瘤元素“硒”以及其它多种维生素。
二、深海鱼骨胶原蛋白1500毫克。
三、鲜鹿茸750毫克或鹿茸腊片细胞250万个。
Claims (9)
1.雪域青稞麦、深海鱼骨胶原蛋白、鹿茸复方保健粥，其特征在于含有雪域青稞粥99％，深海鱼骨胶原0.5％，鹿茸0.5％，加入1％果汁调味。每包装单位净重330-500克。
2.根据权利要求1的复方保健粥，组份选用优质雪域青稞麦、适量矿泉水(国家标准)制粥。
3.根据权利要求1的复方保健粥，添加深海鱼骨胶原蛋白1500毫克。
4.根据权利要求1的复方保健粥，添加鹿茸1500毫克。
5.根据权利要求1的复方保健粥，添加或以专利产品(专利号：200710064481.2)鹿茸腊片细胞250万个替换鹿茸。
6.根据权利要求1的复方保健粥，加入经检测无污染的果汁(苹果、草莓、菠萝)调味。
7.根据权利要求1的复方保健粥，或加入咖啡调味。
8.根据权利要求1的复方保健粥，或加入巧克力调味。
9.根据权利要求1的复方保健粥，精选雪域高原青稞麦，清洗青稞麦干燥，破碎成三分之一碎粒，称重加矿泉水(PH7.2)侵泡1-2小时，置入锅中，以慢火煨煮至粥状， 降温至摄氏20度以下，添加第三、第四或第五组份，加入第六或第七、第八项微量调味，分装入易拉罐封口包装。全程无菌操作。入库冷藏保存。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310341019.8A CN104137965A (zh) | 2013-08-08 | 2013-08-08 | 雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310341019.8A CN104137965A (zh) | 2013-08-08 | 2013-08-08 | 雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104137965A true CN104137965A (zh) | 2014-11-12 |
Family
ID=51847448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310341019.8A Pending CN104137965A (zh) | 2013-08-08 | 2013-08-08 | 雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104137965A (zh) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095511A (zh) * | 2007-07-06 | 2008-01-02 | 韩宗毅 | 青稞虫草八宝粥 |
| CN101310623A (zh) * | 2007-05-23 | 2008-11-26 | 董寅武 | 一种牦牛肉、牛奶、青稞或大米粥 |
| CN101584476A (zh) * | 2009-06-16 | 2009-11-25 | 梁荫健 | 山药、冬虫夏草健体粥 |
| CN101791082A (zh) * | 2010-03-18 | 2010-08-04 | 吴华伟 | 一种茸米养生粥及其制备方法 |
| CN101810268A (zh) * | 2010-04-30 | 2010-08-25 | 西藏天麦力健康品有限公司 | 青稞营养保健食品及其制备方法 |
| CN102028231A (zh) * | 2010-12-31 | 2011-04-27 | 毕跃峰 | 一种富含牛骨胶原蛋白的五谷营养方便粥的配料及其制备方法和应用 |
| CN102178176A (zh) * | 2011-04-06 | 2011-09-14 | 食品行业生产力促进中心 | 一种藏式八宝粥及其制作方法 |
-
2013
- 2013-08-08 CN CN201310341019.8A patent/CN104137965A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101310623A (zh) * | 2007-05-23 | 2008-11-26 | 董寅武 | 一种牦牛肉、牛奶、青稞或大米粥 |
| CN101095511A (zh) * | 2007-07-06 | 2008-01-02 | 韩宗毅 | 青稞虫草八宝粥 |
| CN101584476A (zh) * | 2009-06-16 | 2009-11-25 | 梁荫健 | 山药、冬虫夏草健体粥 |
| CN101791082A (zh) * | 2010-03-18 | 2010-08-04 | 吴华伟 | 一种茸米养生粥及其制备方法 |
| CN101810268A (zh) * | 2010-04-30 | 2010-08-25 | 西藏天麦力健康品有限公司 | 青稞营养保健食品及其制备方法 |
| CN102028231A (zh) * | 2010-12-31 | 2011-04-27 | 毕跃峰 | 一种富含牛骨胶原蛋白的五谷营养方便粥的配料及其制备方法和应用 |
| CN102178176A (zh) * | 2011-04-06 | 2011-09-14 | 食品行业生产力促进中心 | 一种藏式八宝粥及其制作方法 |
Non-Patent Citations (1)
| Title |
|---|
| 夏长春: "《补肾壮阳科学保健滋补食谱》", 31 December 2009 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102077936B (zh) | 一种糖尿病患者专用的海洋特膳食品 | |
| CN102077939B (zh) | 一种肥胖人士专用的海洋特膳食品 | |
| CN102077940B (zh) | 一种冠心病患者专用的海洋特膳食品 | |
| CN102077945B (zh) | 一种人流、产后专用的海洋特膳食品 | |
| CN102077937B (zh) | 一种中青年女士专用的海洋特膳食品 | |
| CN101965969A (zh) | 一种具有抗疲劳和提高免疫功能保健食品组合物及其制备方法和用途 | |
| GB2529962A (en) | Multi-functional composition and preparation method and application thereof | |
| CN101703248A (zh) | 一种含海洋生物活性多糖的肠内营养制剂及其制备方法和用途 | |
| CN102077944B (zh) | 一种前列腺患者专用的海洋特膳食品 | |
| CN103190483A (zh) | 儿童成长奶茶 | |
| CN107495387A (zh) | 一种作为运动补剂的海洋多肽特膳食品 | |
| CN106721855A (zh) | 一种维护男性健康的固体饮品制备方法 | |
| CN103461585B (zh) | 补气养生中药茶 | |
| CN107616507A (zh) | 一种供慢性关节炎患者食用的海洋多肽特膳食品 | |
| CN110447892A (zh) | 一种特殊医学用途氨基酸型肝病全营养配方食品 | |
| CN1718117A (zh) | 黑木耳燕麦螺旋藻即冲饮品及其制备方法 | |
| CN101715989A (zh) | 一种营养鸡汤冻及其制做方法 | |
| CN102077943B (zh) | 一种记忆力衰退者专用的海洋特膳食品 | |
| CN1456097A (zh) | 功能性海洋食品及其生产方法 | |
| CN102077935B (zh) | 一种视力衰退患者专用的海洋特膳食品 | |
| KR101253342B1 (ko) | 비타민을 함유하는 새로운 향미의 마른김 조성물과 그 제조방법 | |
| CN104137965A (zh) | 雪域青稞、深海鱼骨胶原、鹿茸复方系列保健粥 | |
| CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
| CN102077941B (zh) | 一种更年期女士专用的海洋特膳食品 | |
| CN102247523A (zh) | 排毒养颜冲剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination |